StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) income statement

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$32.16+2.64 (+8.94%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Harrow, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
73.3%
Operating margin
-1.0%
Net margin
-13.5%
Return on equity, FY2025
-8.4%

Financial strength

Current ratio
2.24
Debt to equity
19.24
Debt to assets
70.1%
Cash to current liabilities
82.1%

Valuation

P/E ratio
–
Price to sales
4.37
Price to book
79.32
Dividend yield
–

See a number that looks wrong?